PGY-2 Pharmacy Residents in Pharmacotherapy

Developing the future pharmacotherapy specialist

After completing the 12-month PGY-2 Pharmacy Residency in Pharmacotherapy at Mayo Clinic Hospital — Rochester, residents will be proficient independent practitioners capable of providing advanced pharmaceutical care to a multitude of patient populations.

The purpose of the PGY-2 Pharmacy Residency in Pharmacotherapy at Mayo Clinic Hospital — Rochester is to build on doctor of pharmacy education and PGY-1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. This PGY-2 residency provides residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care that improves medication therapy. Residents who successfully complete this accredited PGY-2 pharmacy residency should possess competencies that qualify them for clinical pharmacist and/or faculty positions and position them to be eligible for attainment of board certification in the specialized practice area (when board certification for the practice area exists).

The program provides the high-quality didactic and clinical experiences needed to create a well-rounded, fully competent clinical pharmacist. PGY-2 pharmacotherapy residents:

  • Develop expertise, knowledge and skills in pharmacologic therapies
  • Contribute to an interdisciplinary health care team offering patient-specific therapeutic interventions to treat, cure, rehabilitate and alleviate medical conditions and diseases
  • Enhance skills in conducting clinical research
  • Strengthen communication skills by presenting formal and informal lectures, writing a professional manuscript, and leading interdisciplinary discussions

The PGY-2 pharmacotherapy residency provides opportunities for advanced training in all areas of pharmacy practice. During each learning experience, residents work closely with their preceptors, highly qualified pharmacists, physicians and other allied health care professionals.

Program history

The PGY-2 Pharmacy Residency in Pharmacotherapy at Mayo Clinic Hospital — Rochester was originally accredited by the American Society of Health-System Pharmacists (ASHP) in 2007 and has produced respected clinicians that practice across the U.S. The residency program is continuously evaluated for improvement opportunities to ensure graduates make a seamless transition into clinical practice. One candidate a year is selected on a competitive basis.

Dedicated preceptors

Preceptors for the PGY-2 pharmacotherapy residency provide direct patient care in virtually every specialty area and are actively involved in resident teaching and other scholarly activities. The preceptors come from diverse backgrounds and share numerous years of experience, clinical knowledge and research interests. Residents have direct access to preceptors and mentors to optimize the learning experience.

More than 100 pharmacists at Mayo Clinic are certified by the Board of Pharmacy Specialties in various practice areas. All residency program preceptors meet the qualifications outlined by the ASHP.


The campus in Rochester, Minnesota, is divided between outpatient and inpatient facilities. The extensive outpatient facilities are part of Mayo Clinic, while Mayo Clinic Hospital — Rochester includes the Saint Marys campus (1,265 beds) and the Methodist campus (794 beds). Together, these represent one of the largest, most advanced medical centers in the world.

Training for this residency is primarily conducted at Mayo Clinic Hospital — Rochester, though students may have learning experiences at Mayo Eugenio Litta Children's Hospital or Mayo Clinic's outpatient complex.

Nov. 14, 2016